Anisakis simplex:: The activity of larval products on the complement system

被引:8
作者
Garcia-Hernandez, P. [1 ]
Rodero, M. [1 ]
Cuellar, C. [1 ]
机构
[1] Univ Complutense Madrid, Fac Farm, Dept Parasitol, E-28040 Madrid, Spain
关键词
Anisakis simplex; complement system; alternative pathway; classical pathway; C3-deficient serum; third-stage larvae; excretory-secretory; crude extract; phosphate-buffered saline; human pooled serum; rabbit erythrocytes; sheep erythrocytes; ethylenebis(oxyethylenenitrilo) tetraacetic acid; veronal saline buffer; sensitized sheep erythrocytes; IC50 concentration giving 50% haemolysis inhibition; phenylmethanesulfonyl fluoride;
D O I
10.1016/j.exppara.2006.04.013
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The effects of the larval products (crude extract and excretory-secretory) of Anisakis simplex on the classical and alternative pathways of human complement system were investigated. This could constitute a mechanism to evade host defences, similarly than in other parasitic diseases. The larval products showed a stronger effect on the classical pathway than on the alternative pathway. The most pronounced modulating effects were found for the excretory-secretory products. Chelation of bivalent cations (Ca2(+) or Mg2(+)) by these larval products may be responsible for their mode of action on the alternative pathway, whereas the chelation is not likely to be particularly involved in the anticomplementary activity found on the classical pathway. Detailed studies revealed that the larval products of A. simplex act at the level of the C3 and other complement components. Heating the crude parasite extract led to a notable loss of haemolysis inhibition activity, and the addition of PMSF (a serine protease inhibitor) also cause variation in the activity of the crude extract. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 24 条
  • [1] A TRYPANOSOMA-CRUZI SECRETED PROTEIN IMMUNOLOGICALLY RELATED TO THE COMPLEMENT COMPONENT-C9 - EVIDENCE FOR MEMBRANE PORE-FORMING ACTIVITY AT LOW PH
    ANDREWS, NW
    ABRAMS, CK
    SLATIN, SL
    GRIFFITHS, G
    [J]. CELL, 1990, 61 (07) : 1277 - 1287
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] BRECKENRIDGE RT, 1977, J IMMUNOL, V118, P12
  • [4] Diaz A, 1997, J IMMUNOL, V158, P3779
  • [5] THE ROLE OF COMPLEMENT IN INFLAMMATION AND PHAGOCYTOSIS
    FRANK, MM
    FRIES, LF
    [J]. IMMUNOLOGY TODAY, 1991, 12 (09): : 322 - 326
  • [6] Halkes S. B. A., 1997, PHARM PHARM LETT, V2, P79
  • [7] Comparison of complement activation in vitro by different Echinococcus granulosus extracts
    Irigoin, F
    Wurzner, R
    Sim, RB
    Ferreira, AM
    [J]. PARASITE IMMUNOLOGY, 1996, 18 (07) : 371 - 375
  • [8] Characteristics of anti-complementary biopolymer extracted from Coriolus versicolor
    Jeong, SC
    Yang, BK
    Ra, KS
    Wilson, MA
    Cho, Y
    Gu, YA
    Song, CH
    [J]. CARBOHYDRATE POLYMERS, 2004, 55 (03) : 255 - 263
  • [9] ANTICOMPLEMENTARY ACTIVITY OF BOSWELLIC ACIDS - AN INHIBITOR OF C3-CONVERTASE OF THE CLASSICAL COMPLEMENT PATHWAY
    KAPIL, A
    MOZA, N
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (07): : 1139 - 1143
  • [10] Inhibition of human complement by beta-glycyrrhetinic acid
    Kroes, BH
    Beukelman, CJ
    vandenBerg, AJJ
    Wolbink, GJ
    vanDijk, H
    Labadie, RP
    [J]. IMMUNOLOGY, 1997, 90 (01) : 115 - 120